Purchase Order 75N95023P00654

Award Date 9/7/23
Potential Completion Date 11/6/23
Potential Value $21K
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portland, OR 97201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,999 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (part of the U.S. Department of Health and Human Services) to Apdm Wearable Technologies Inc., a for-profit manufacturer of wearable technologies. The contract is for a "Mobility Lab System: Gait and Posture Analysis System" including all items listed on the provided quote. This contract has no set-aside designation and was awarded on September 17, 2014 with a...
The Department of the Army Materiel Command Research Development and Engineering Command awarded a $171,998.00 firm fixed price purchase order to Apdm, Inc., a for-profit manufacturer of digital health and wearable sensor technologies, for the delivery of V2 KIT 12 OPAL MOTION STUDIO systems. The contract has no set-aside designation and the period of performance ends on September 30, 2020. Apdm, Inc. has previously provided wearable sensor technologies and motion analysis systems to support...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $58,988.72 firm fixed price purchase order to Actigraph L.L.C., doing business as Actigraph LLC, located in Pensacola, Florida. Under the terms of the award, Actigraph will provide ACTIGRAPH CENTREPOINT INSIGHT WATCHES to the agency through August 15, 2026. As the leading federal funder of biomedical research, the National Institutes of Health aims to...
This contract award is for the delivery of 8 units of the V2 OPAL wearable sensor system, along with 2 units each of small and medium straps, to the Defense Health Agency (DHA), a component of the Department of Defense. The firm fixed-price contract was awarded to Apdm Wearable Technologies Inc., a for-profit manufacturer of wearable technologies, on September 27, 2019 with a ceiling value of $16,088.00 and a completion date of October 31, 2019. There is no set-aside designation mentioned....
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Apdm Wearable Technologies Inc., a for-profit manufacturer of wearable technologies. The $20,521 contract is for the provision of wearable bio sensors, with a period of performance through September 30, 2024. Apdm has been awarded over $300,000 in prior federal contracts and grants from agencies such as the Department of Health and Human Services, Department of Veterans Affairs, and Department of the Army...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446.64 firm fixed price purchase order to Eurofins Discoverx Corporation of Fremont, California. The purchase order is for GPCRMAX PANEL services and will be performed between June 26, 2023 and September 30, 2023 in Fremont. The National Institute of Neurological Disorders and Stroke supports research on brain and nervous system disorders to reduce...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $15,036 firm fixed price purchase order to National Instruments Corp for a digitizer module. Performance will occur in Bethesda, Maryland by May 2024. As a manufacturer of automated test and measurement systems, National Instruments will provide the requested module to support the agency's biomedical research efforts. No set-aside designation was applied...
This is a $6,005.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse, part of the U.S. Department of Health and Human Services, to ActiGraph LLC, a for-profit company that provides specialized wearable devices, data hubs, and software for biomedical research. The contract has no set-aside designation. Based on the company's previous federal contracts with other NIH institutes, ActiGraph appears to specialize in providing advanced wearable technology and data...
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $18,406.83 firm fixed price purchase order to Andor Technology, Inc. of Concord, Massachusetts. The award is for an annual software license of IMARIS for core facilities to support the agency's biomedical research efforts. Performance will take place in Concord, Massachusetts over a one year period ending in September 2024. No set aside designation or...
The Department of Health and Human Services' National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $35,463.53 firm fixed price purchase order to Andor Technology, Inc. of Bethesda, Maryland. The contract is for the delivery of Andor's IMARIS 10.0 software package to support the agency's research efforts. No major subcontractors or set aside designations were identified. This award will provide the NIH NINDS with Andor's image processing and analysis...

The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,615 purchase order to Apdm Wearable Technologies Inc. of Portland, Oregon. Under the terms of the firm fixed price contract, Apdm will provide 6-OPAL MOBILITY LAB SYSTEMS to NIH/NINDS in support of its biomedical research efforts. Work will be conducted in Portland through November 6, 2023. No subcontractors or set aside designations were identified. The award utilizes Apdm's expertise in wearable technologies to further NIH/NINDS's mission of reducing the burden of neurological disease.

Generated 12/15/23, 1:41 PM